The Goldman Sachs Group Has Lowered Expectations for 10x Genomics (NASDAQ:TXG) Stock Price
10x Genomics (NASDAQ:TXG – Get Free Report) had its price target reduced by analysts at The Goldman Sachs Group from $7.50 to $6.50 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “sell” rating on the stock. The Goldman Sachs Group’s price target suggests a potential downside of 32.64% […]
10x Genomics (NASDAQ:TXG – Get Free Report) had its price target reduced by analysts at The Goldman Sachs Group from $7.50 to $6.50 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “sell” rating on the stock. The Goldman Sachs Group’s price target suggests a potential downside of 32.64% […]
